NASA’s acting chief technologist, Dr Douglas Terrier, made the comments ahead of an appearance at the Codex innovation summit, held in London.

One of the techniques currently under development that it is following is NMN, a compound expected to enter clinical trials after it was shown to rejuvenate elderly mice in laboratory tests.